查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腦炎治療市場與 COVID-19 影響分析，按類型、治療、症狀、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1335280

腦炎治療市場與 COVID-19 影響分析，按類型、治療、症狀、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Encephalitis Treatment Market with COVID-19 Impact Analysis, By Type, By Treatment, By Symptoms, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年腦炎治療市場規模為201.089億美元，2023年至2030年年複合成長率為5.3%。

腦炎治療市場-市場動態：

  • 腦炎患病率不斷上升推動市場成長。
  • 預計腦炎病例的增加將推動全球腦炎治療市場的發展。一種隨著時間的推移而變得更嚴重的揮之不去的腦部炎症稱為 CFE。大腦的大腦半球經常受到炎症的影響，從而導致嚴重的癲癇活動，例如反復發作的局灶性癲癇發作。由於持續的腦部炎症，患有 CFE 的人可能會出現不可挽回的腦損傷、運動能力喪失和精神惡化。這種疾病主要影響 2 至 10 歲的兒童，全球僅記錄了 200 至 500 例病例。因此，上述事實支持預測期內的市場成長。

腦炎治療市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，預計全球腦炎治療市場在預測期內（2023-2030）每年將以 5.3% 左右的年複合成長率成長
  • 由於全球腦炎的高發病率，預計腦炎治療行業將以顯著的速度成長
  • 根據類型細分，預計主要細分市場將在預測期內主導市場
  • 從地區來看，預計北美將在預測期內主導市場

腦炎治療市場-細分分析：

  • 全球腦炎治療市場根據類型、治療、症狀、最終用戶和地區進行細分。
  • 根據類型，市場分為初級市場和次級市場。預計主要細分市場將在預測期內主導市場。該細分市場的成長歸因於原發性腦炎相對於繼發性腦炎的患病率不斷上升。原發性腦炎是指由感染原直接引起腦部炎症，而身體其他部位沒有任何先前感染的情況。引起原發性腦炎的常見傳染源包括單純皰疹病毒 (HSV)、西尼羅河病毒 (WNV) 和腸道病毒等病毒。 HSV 腦炎是最嚴重的原發性腦炎之一，需要立即就醫。如果不及時治療，可能會導致嚴重的腦損傷和神經併發症。從而推動細分市場的擴張。

腦炎治療市場-地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內主導市場。腦炎病例遍布北美，其患病率因地區和腦炎類型（例如病毒性、自身免疫性）而異。據報導，病毒性腦炎，例如單純皰疹腦炎，是美國散發性腦炎的主要原因之一。此外，北美，特別是美國，一直處於腦炎研究和臨床試驗的前沿。許多學術機構、製藥公司和研究組織都積極參與腦炎發病機制的研究、確定新的治療方式和探索潛在的疫苗。因此，預計這將推動該地區的市場成長。

腦炎治療市場-競爭格局：

全球腦炎治療市場的領先公司正在加大研發力度，以使其產品多樣化。此外，這些市場參與者利用戰略聯盟和合作夥伴關係來促進成長。市場上的主要參與者包括艾爾建、默克公司、輝瑞公司、葛蘭素史克公司、Melinta Therapeutics LLC、Basilea Pharmaceutica Ltd.、雅培、F. Hoffmann-La Roche Ltd.、Mylan NV、Teva Pharmaceutical Industries Ltd.、賽諾菲、諾華公司、拜耳公司、Sun Pharmaceutical Industries Ltd.、Aurobindo Pharma、Lupin、艾伯維公司、Cumberland Pharmaceuticals Inc.、禮來公司、Endo International plc、Zydus Cadila 和Fresenius Kabi AG。

最近的發展：

2021 年 8 月，蜱傳腦炎 (TBE) 疫苗（稱為 TICOVAC）獲得美國食品和藥物管理局 (USFDA) 批准。在野外，它可以產生 TBE 病毒中和抗體。白蛋白是人類血液的一種成分，存在於 TICOVAC 中。由於有效的供體篩选和產品加工程序，病毒傳播和變異型克雅氏病 (vCJD) 傳播的可能性極低。

該研究的主要特點：

  • 這項關於腦炎治療市場的擬議研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030），以 2022 年為基準年
  • 該報告為客戶提供有關腦炎治療市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了腦炎治療市場有吸引力的投資主張矩陣
  • 總體報告確定了新的投資機會、老牌參與者面臨的挑戰以及腦炎治療市場維持的成長因素
  • COVID-19 對腦炎治療市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將涵蓋新冠疫情后腦炎治療市場的詳細見解。
  • 為了讓本報告的用戶全面了解腦炎治療市場，我們還包括了腦炎治療市場的競爭格局和關鍵創新者分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這將幫助用戶了解腦炎治療市場參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球腦炎治療市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師

目錄

第一章：腦炎治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的腦炎治療市場片段
    • 腦炎治療市場片段（按治療）
    • 按症狀分類的腦炎治療市場片段
    • 最終用戶的腦炎治療市場片段
    • 按國家/地區分類的腦炎治療市場片段
    • 按地區分類的腦炎治療市場片段
  • 競爭洞察

第 3 章：腦炎治療主要市場趨勢

  • 腦炎治療市場促進因素
    • 市場促進因素的影響分析
  • 腦炎治療市場限制
    • 市場限制影響分析
  • 腦炎治療市場機會
  • 腦炎治療市場未來趨勢

第 4 章：腦炎治療行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：腦炎治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：腦炎治療市場格局

  • 2022 年腦炎治療市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：腦炎治療市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 原發性腦炎
    • 繼發性腦炎

第 8 章：腦炎治療市場 - 按治療分類

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 抗病毒劑
    • 類固醇注射
    • 抗生素
    • 免疫球蛋白治療
    • 血漿分離術
    • 其他

第 9 章：腦炎治療市場 - 按症狀

  • 概述
    • 按症狀分類的細分市場佔有率分析
    • 發燒
    • 睡意
    • 頭痛
    • 性格改變
    • 易怒
    • 錯亂
    • 弱點
    • 癲癇發作
    • 其他

第 10 章：腦炎治療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 診所
    • 醫院
    • 其他

第 11 章：腦炎治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 北美腦炎治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按不同處理方式）
    • 北美市場規模和預測（按症狀）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲腦炎治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按類型）
    • 歐洲市場規模和預測（按處理方式）
    • 歐洲市場規模和預測（按症狀）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區腦炎治療主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按類型）
    • 亞太地區市場規模和預測（按不同處理方式）
    • 亞太地區市場規模和預測（按症狀）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲腦炎治療主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按類型）
    • 拉丁美洲市場規模和預測（按不同處理方式）
    • 拉丁美洲市場規模和預測（按症狀）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲腦炎治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按不同處理方式）
    • 中東和非洲市場規模及預測（按症狀）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章：主要供應商分析-腦炎治療行業

  • 競爭儀表板
  • 公司簡介
    • Allergan
    • Merck & Co., Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Melinta Therapeutics LLC
    • Basilea Pharmaceutica Ltd.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Novartis AG
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • AbbVie Inc.
    • Cumberland Pharmaceuticals Inc.
    • Eli Lilly and Company
    • Endo International plc
    • Zydus Cadila
    • Fresenius Kabi AG

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1573

REPORT HIGHLIGHT

Encephalitis Treatment Market size was valued at USD 20,108.9 Million in 2022, expanding at a CAGR of 5.3% from 2023 to 2030.

An infection or an inflammatory reaction that affects the brain's active tissues might result in encephalitis. The goal of encephalitis treatment is to reduce head swelling and avert complications. Intravenous antibiotics can be administered to treat encephalitis if a bacterial infection is to blame. Herpes-related encephalitis is treated with supportive care and intravenous antiviral drugs including acyclovir. The patient should also be kept hydrated, their temperature should be reduced, and seizures should be treated, and any pressure in their skull should be eased.

Encephalitis Treatment Market- Market Dynamics:

  • Growing prevalence of encephalitis to propel market growth.
  • An increase in encephalitis cases is anticipated to fuel the global market for encephalitis treatments. A type of lingering brain inflammation that becomes worse over time is called CFE. The cerebral hemisphere of the brain is often affected by inflammation, which causes severe epileptic activity such as recurring focal seizures. Because of the ongoing brain inflammation, people with CFE may have irreparable brain damage, loss of motor abilities, and mental deterioration. The sickness mostly affects children between the ages of 2 and 10, and there have only been 200-500 recorded cases worldwide. Thereby, the aforementioned facts support the market growth during the forecast period.

Encephalitis Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Encephalitis Treatment market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2023-2030)
  • The Encephalitis Treatment industry is projected to grow at a significant rate owing to the high prevalence of encephalitis across the globe
  • Based on type segmentation, the primary segment is expected to dominate the market during the forecast period
  • Based on region, North America is expected to dominate the market over the forecast period

Encephalitis Treatment Market- Segmentation Analysis:

  • The Global Encephalitis Treatment Market is segmented based on type, treatment, symptoms, end user, and Region.
  • Based on type, the market is bifurcated into primary and secondary. The primary segment is expected to dominate the market during the forecast period. The segment growth is attributed to the growing prevalence of primary encephalitis over secondary encephalitis. Primary encephalitis refers to cases where the inflammation of the brain is directly caused by an infectious agent, without any prior infection in other parts of the body. Common infectious agents causing primary encephalitis include viruses like herpes simplex virus (HSV), West Nile virus (WNV), and enteroviruses. HSV encephalitis is one of the most severe forms of primary encephalitis and requires immediate medical attention. It can lead to significant brain damage and neurological complications if not treated promptly. Thereby, driving the segment expansion.

Encephalitis Treatment Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. Encephalitis cases occur throughout North America, with varying prevalence rates depending on the region and the type of encephalitis (e.g., viral, autoimmune). Viral encephalitis, such as herpes simplex encephalitis, has been reported to be one of the leading causes of sporadic encephalitis in the United States. Moreover, North America, particularly the United States, has been at the forefront of encephalitis research and clinical trials. Many academic institutions, pharmaceutical companies, and research organizations are actively involved in studying the pathogenesis of encephalitis, identifying new treatment modalities, and exploring potential vaccines. Thus, this is expected to drive the market growth in the region.

Encephalitis Treatment Market- Competitive Landscape:

Leading companies in the worldwide Encephalitis Treatment market are stepping up their R&D efforts to diversify their product offerings. Additionally, these market participants use strategic alliances and partnerships that promote growth. The key players operating in the market include Allergan, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Eli Lilly and Company, Endo International plc, Zydus Cadila, and Fresenius Kabi AG.

Recent Developments:

In August 2021, the Tick-Borne Encephalitis (TBE) vaccine, known as TICOVAC, was approved by the United States Food and Drug Administration (USFDA). In the wild, it can generate TBE virus-neutralizing antibodies. Albumin, a component of human blood, is present in TICOVAC. Virus transmission and variant Creutzfeldt-Jakob disease (vCJD) transmission are extremely unlikely due to effective donor screening and product processing procedures.

Key features of the study:

  • This proposed research study on Encephalitis Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Encephalitis Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Encephalitis Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Encephalitis Treatment market
  • Impact of COVID-19 on Encephalitis Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Encephalitis Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Encephalitis Treatment market, we have also included competitive landscape and key innovator analysis for the Encephalitis Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Encephalitis Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Encephalitis Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENCEPHALITIS TREATMENT MARKET KEY PLAYERS

  • Allergan
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Melinta Therapeutics LLC
  • Basilea Pharmaceutica Ltd.
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • AbbVie Inc.
  • Cumberland Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Endo International plc
  • Zydus Cadila
  • Fresenius Kabi AG

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TYPE

  • Primary Encephalitis
  • Secondary Encephalitis

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY TREATMENT

  • Antiviral Agents
  • Steroid Injection
  • Antibiotics
  • Immunoglobulin Therapy
  • Plasmapheresis
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY SYMPTOMS

  • Fever
  • Drowsiness
  • Headaches
  • Personality Changes
  • Irritability
  • Confusion
  • Weakness
  • Seizures
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY END USER

  • Clinic
  • Hospital
  • Others

GLOBAL ENCEPHALITIS TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Encephalitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Encephalitis Treatment Market Snippet by Type
    • 2.1.2. Encephalitis Treatment Market Snippet by Treatment
    • 2.1.3. Encephalitis Treatment Market Snippet by Symptoms
    • 2.1.4. Encephalitis Treatment Market Snippet by End User
    • 2.1.5. Encephalitis Treatment Market Snippet by Country
    • 2.1.6. Encephalitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Encephalitis Treatment Key Market Trends

  • 3.1. Encephalitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Encephalitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Encephalitis Treatment Market Opportunities
  • 3.4. Encephalitis Treatment Market Future Trends

4. Encephalitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Encephalitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Encephalitis Treatment Market Landscape

  • 6.1. Encephalitis Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Encephalitis Treatment Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Primary Encephalitis
    • 7.1.3. Secondary Encephalitis

8. Encephalitis Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 8.1.2. Antiviral Agents
    • 8.1.3. Steroid Injection
    • 8.1.4. Antibiotics
    • 8.1.5. Immunoglobulin Therapy
    • 8.1.6. Plasmapheresis
    • 8.1.7. Others

9. Encephalitis Treatment Market - By Symptoms

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Symptoms, 2022 & 2030 (%)
    • 9.1.2. Fever
    • 9.1.3. Drowsiness
    • 9.1.4. Headaches
    • 9.1.5. Personality Changes
    • 9.1.6. Irritability
    • 9.1.7. Confusion
    • 9.1.8. Weakness
    • 9.1.9. Seizures
    • 9.1.10. Others

10. Encephalitis Treatment Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Clinic
    • 10.1.3. Hospital
    • 10.1.4. Others

11. Encephalitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Encephalitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Encephalitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Encephalitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Encephalitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Encephalitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Symptoms, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Encephalitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Allergan
    • 12.2.2. Merck & Co., Inc.
    • 12.2.3. Pfizer Inc.
    • 12.2.4. GlaxoSmithKline plc
    • 12.2.5. Melinta Therapeutics LLC
    • 12.2.6. Basilea Pharmaceutica Ltd.
    • 12.2.7. Abbott
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Mylan N.V.
    • 12.2.10. Teva Pharmaceutical Industries Ltd.
    • 12.2.11. Sanofi
    • 12.2.12. Novartis AG
    • 12.2.13. Bayer AG
    • 12.2.14. Sun Pharmaceutical Industries Ltd.
    • 12.2.15. Aurobindo Pharma
    • 12.2.16. Lupin
    • 12.2.17. AbbVie Inc.
    • 12.2.18. Cumberland Pharmaceuticals Inc.
    • 12.2.19. Eli Lilly and Company
    • 12.2.20. Endo International plc
    • 12.2.21. Zydus Cadila
    • 12.2.22. Fresenius Kabi AG

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Encephalitis Treatment Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Encephalitis Treatment Market, by Type 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Encephalitis Treatment Market, by Treatment 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Symptoms Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Symptoms
  • TABLE Global Encephalitis Treatment Market, by Symptoms 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Encephalitis Treatment Market, by End User 2018-2030 (USD Million)
  • TABLE Encephalitis Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Encephalitis Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE North America Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Europe Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Asia Pacific Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Latin America Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by Symptoms, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Encephalitis Treatment Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Encephalitis Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Treatment segment market share analysis, 2022 & 2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Symptoms segment market share analysis, 2022 & 2030
  • FIGURE Symptoms segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Europe Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Latin America Encephalitis Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Encephalitis Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Germany Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE India Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Brazil Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Encephalitis Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Encephalitis Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)